telemedicine compounded semaglutide weight loss management now available for patients in California, Arizona, Hawaii and Florida VivioMD GLP-1 Telehealth Program (2026):

The concern about lean mass loss is valid, but the framing here is misleading

How Triple Agonism Differs Pharmacologically The research appeal of triple agonists like retatrutide lies in the combination of three biological effects: GLP-1 receptor activation: Increased insulin secretion (glucose-dependent), reduced glucagon secretion, delayed gastric emptying, appetite reduction

Zepbound (Tirzepatide) Zepbound is another once-weekly injectable medication, targeting both GLP-1 and GIP receptors

Recommended dose: Take 1 capsule daily

A: Potentially, yesbut that decision should be made with your physician based on your health status